The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.

Me announced on Monday it would cut approximately 40% of its workforce, impacting over 200 employees. The restructuring ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Three years ago, the DNA-testing firm 23andMe was a massive success, with a share price higher than Apple's. But, from those ...

23andMe, a leading name in the genetic testing business, has revealed plans to lay off some 200 employees ... The breached ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...

Unlike Ancestry, 23andMe does have FDA approval as a risk screener for a handful of genetic conditions and diseases. If you're primarily interested in DNA testing for this purpose, 23andMe is ...

23andMe Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, ...